Cardiovascular Devices: Interventional Cardiology Devices

• Publication date: August 2010

Industry expert's new report, “” provides key data, information and analysis on the global interventional cardiology devices industry . The report provides industry landscape, competitive landscape and industry trends information the interventional cardiology devices industry . The report provides comprehensive data on the major industry developments affecting the industry, and key analytical content on the industry dynamics. The rep...

Industry expert's new report, “” provides key data, information and analysis on the global interventional cardiology devices industry . The report provides industry landscape, competitive landscape and industry trends information the interventional cardiology devices industry . The report provides comprehensive data on the major industry developments affecting the industry, and key analytical content on the industry dynamics. The report also reviews the competitive landscape and technology offerings.

Scope of the Research

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key sectors covered include Cardiac Catheters (Guiding Catheters, Angiography Catheters), Coronary Guidewires, Coronary Stents (Bare Metal Stents, Drug Eluting Stents), PTCA Balloons (FW Balloons, Over the Wire Balloons, Rx balloons), and Arteriotomy Closure Devices.
- Annualized industry revenues data from 2002 to 2009, projection forward for 7 years to 2016. Firms shares data for 2009.
- Qualitative analysis of key industry trends, industry drivers, and restraints by each category within interventional cardiology devices industry .
- The report also covers data on the leading industry players, the competitive landscape, and the leading new product development and technologies.
- Key Companies covered include Boston Scientific Corporation, Cordis Corporation, Abbott Laboratories, Medtronic, and Terumo Corporation.

Why Should You Get This Report?

- Develop business strategies by understanding the trends and developments that are driving the interventional cardiology devices industry globally.
- Design and develop your product development, industry ing and sales strategies.
- Develop successful market-entry strategies .
- Identify key players best positioned to take advantage of the emerging industry opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the interventional cardiology devices industry landscape? – Identify, understand and decide.
- Make more informed business decisions from the insightful and in-depth analysis of the global interventional cardiology devices industry and the factors shaping it.

Global Cardiovascular Devices Industry

1 Table of contents 3
I. 1 List of Data tables 6
I. 2 List of Charts 8
2 Disease Data : Coronary Heart Disease (CHD) 9
II. 1 Introduction 9
II. 2 Etiology 9
II. 3 Pathophysiology 9
II. 4 Symptoms 10
II. 5 Risk Factors 10
II. 6 Epidemiology 11
II. 6.1 Prevalence of CHD in the US 11
II. 6.2 Prevalence of CHD in the EU 11
II. 7 Device Based Treatments 11

III Device Overview 12
III. 1 Cardiac Catheter 12
III. 1.1 Angiography Catheter 12
III. 1.2 Guiding Catheter 13
III. 2 Coronary Guidewire 13
III. 3 Coronary Stent 13
III. 3.1 Bare Metal Stent (BMS) 13
III. 3.2 Drug Eluting Stent (DES) 13
III. 4 PTCA Balloon 14
III. 4.1 FW Balloon 14
III. 4.2 Over the Wire Balloon 14
III. 4.3 Rapid Exchange Balloon 14
III. 5 Arteriotomy Closure Device 14
4 World Interventional Cardiology Devices March ket: March ket Characterization 15
IV. 1 World Interventional Cardiology Devices March ket, Sales (USD Million), Historical data, 2002–2009 15
IV. 2 World Interventional Cardiology Devices March ket, Sales (USD Million), Forecasted data s, 2009–2016 16
IV. 3 World Interventional Cardiology Devices March ket, Key Trends 17
IV. 4 World Interventional Cardiology Devices, March ket Dynamics 18
IV. 4.1 March ket Drivers 18
IV. 4.2 March ket Restraints 19
5 World Cardiac Catheter March ket: March ket Characterization 20
V. 1 World Cardiac Catheter March ket, Sales (USD Million), Historical data, 2002–2009 20
V. 2 World Cardiac Catheter March ket, Sales (USD Million), Forecasted data s, 2009–2016 21
V. 3 World Cardiac Catheter, March ket Dynamics 22
V. 3.1 March ket Drivers 22
V. 3.2 March ket Restraints 22
6 World Coronary Guidewire March ket: March ket Characterization 23
VI. 1 World Coronary Guidewire March ket, Sales (USD Million), Historical data, 2002–2009 23
VI. 2 World Coronary Guidewire March ket, Sales (USD Million), Forecasted data s, 2009–2016 24
VI. 3 World Coronary Guidewire, March ket Dynamics 25
VI. 3.1 March ket Drivers 25
VI. 3.2 March ket Restraints 25
7 World Coronary Stent March ket: March ket Characterization 26
VII. 1 World Coronary Stent March ket, Sales (USD Million), Historical data, 2002–2009 26
VII. 2 World Coronary Stent March ket, Sales (USD Million), Forecasted data s, 2009–2016 27
VII. 3 World Coronary Stent, March ket Dynamics 28
VII. 3.1 March ket Drivers 28
VII. 3.2 March ket Restraints 29
8 World PTCA Balloon March ket: March ket Characterization 30
VIII. 1 World PTCA Balloon March ket, Sales (USD Million), Historical data, 2002–2009 30
VIII. 2 World PTCA Balloon March ket, Sales (USD Million), Forecasted data s, 2009–2016 31
VIII. 3 World PTCA Balloon, March ket Dynamics 32
VIII. 3.1 March ket Drivers 32
VIII. 3.2 March ket Restraints 32
9 World Arteriotomy Closure Devices March ket: March ket Characterization 33
IX. 1 World Arteriotomy Closure Devices March ket, Sales (USD Million), Historical data, 2002–2009 33
IX. 2 World Arteriotomy Closure Devices March ket, Sales (USD Million), Forecasted data s, 2009–2016 34
IX. 3 World Arteriotomy Closure Devices, March ket Dynamics 34
IX. 3.1 March ket Drivers 34
IX. 3.2 March ket Restraints 35

X Global Interventional Cardiology Devices March ket: March ket Analysis and Forecasted data s by Country 36
X. 1 World Interventional Cardiology Devices March ket: March ket Analysis by Country 36
X. 2 Interventional Cardiology Devices March ket, Sales (USD Million), By Country, Historical data and Forecasted data s, 2002–2016 37
X. 2.1 Interventional Cardiology Devices March ket, The US, Sales (USD Million), Historical data, 2002–2009 37
X. 2.2 Interventional Cardiology Devices March ket, The US, Sales (USD Million), Forecasted data s, 2009–2016 38
X. 2.3 Interventional Cardiology Devices March ket, Canada, Sales (USD Million), Historical data, 2002–2009 39
X. 2.4 Interventional Cardiology Devices March ket, Canada, Sales (USD Million), Forecasted data s, 2009–2016 40
X. 2.5 Interventional Cardiology Devices March ket, The UK, Sales (USD Million), Historical data, 2002–2009 41
X. 2.6 Interventional Cardiology Devices March ket, The UK, Sales (USD Million), Forecasted data s, 2009–2016 42
X. 2.7 Interventional Cardiology Devices March ket, France, Sales (USD Million), Historical data, 2002–2009 43
X. 2.8 Interventional Cardiology Devices March ket, France, Sales (USD Million), Forecasted data s, 2009–2016 44
X. 2.9 Interventional Cardiology Devices March ket, Germany, Sales (USD Million), Historical data, 2002–2009 45
X. 2.10 Interventional Cardiology Devices March ket, Germany, Sales (USD Million), Forecasted data s, 2009–2016 46
X. 2.11 Interventional Cardiology Devices March ket, Italy, Sales (USD Million), Historical data, 2002–2009 47
X. 2.12 Interventional Cardiology Devices March ket, Italy, Sales (USD Million), Forecasted data s, 2009–2016 48
X. 2.13 Interventional Cardiology Devices March ket, Spain, Sales (USD Million), Historical data, 2002–2009 49
X. 2.14 Interventional Cardiology Devices March ket, Spain, Sales (USD Million), Forecasted data s, 2009–2016 50
X. 2.15 Interventional Cardiology Devices March ket, Japan, Sales (USD Million), Historical data, 2002–2009 51
X. 2.16 Interventional Cardiology Devices March ket, Japan, Sales (USD Million), Forecasted data s, 2009–2016 52
X. 2.17 Interventional Cardiology Devices March ket, China, Sales (USD Million), Historical data, 2002–2009 53
X. 2.18 Interventional Cardiology Devices March ket, China, Sales (USD Million), Forecasted data s, 2009–2016 54
X. 2.19 Interventional Cardiology Devices March ket, Australia, Sales (USD Million), Historical data, 2002–2009 55
X. 2.20 Interventional Cardiology Devices March ket, Australia, Sales (USD Million), Forecasted data s, 2009–2016 56
X. 2.21 Interventional Cardiology Devices March ket, India, Sales (USD Million), Historical data, 2002–2009 57
X. 2.22 Interventional Cardiology Devices March ket, India, Sales (USD Million), Forecasted data s, 2009–2016 58
X. 2.23 Interventional Cardiology Devices March ket, Brazil, Sales (USD Million), Historical data, 2002–2009 59
X. 2.24 Interventional Cardiology Devices March ket, Brazil, Sales (USD Million), Forecasted data s, 2009–2016 60

XI Global Interventional Cardiology Devices March ket: Strategic Competitive Assessment 61
XI. 1 World Interventional Cardiology Devices March ket, Key Market Shares s (%), 2009 61
XI. 2 World Interventional Cardiology Devices March ket: Key March ket Participants 62
XI. 2.1 Boston Scientific Corporation 62
XI. 2.2 Cordis Corporation 63
XI. 2.3 Abbott Laboratories 65
XI. 2.4 Medtronic, Inc. 66
XI. 2.5 Terumo Corporation 67

XII Key Interventional Cardiology Devices in the March ket 69
XII. 1 Cardiac Catheters 69
XII. 1.1 FIRE STAR PTCA Dilatation Catheter 69
XII. 1.2 Apex Monorail PTCA Dilation Catheters 69
XII. 2 Coronary Guidewires 70
XII. 2.1 GTX Guidewires 70
XII. 2.2 BALANCE HI-TORQUE PILOT Coronary GuideWire 70
XII. 3 Coronary Stents 71
XII. 3.1 PROMUS Everolimus-Eluting Coronary Stent System 71
XII. 3.2 CYPHER Sirolimus-eluting Coronary Stent 71
XII. 3.3 Endeavor ABT-578 Eluting Coronary Stent System 72
XII. 3.4 TAXUS Express² Coronary Stent System 72
XII. 4 Arteriotomy Closure Devices 73
XII. 4.1 StarClose Vascular Closure System 73

XIII Global Interventional Cardiology Devices: Strategic Pipeline Assessment 74
XIII. 1 Interventional Cardiology Devices: Pipeline Products Summary 74
XIII. 2 Profiles of Promising Products under Clinical Development 75
XIII. 2.1 Cardiac Catheters 75
XIII. 2.2 Coronary Guidewires 75
XIII. 2.3 Coronary Stents 77
XIII. 2.4 PTCA Balloons 78
XIII. 2.5 Arteriotomy Closure Devices 79
XIII. 3 Interventional Cardiology Devices: List of Pipeline Products 81
XIII. 3.1 Cardiac Catheters 81
XIII. 3.2 Coronary Guidewire 82
XIII. 3.3 Arteriotomy Closure Devices 82
XIII. 3.4 PTCA Balloon 83
XIII. 3.5 Coronary Stents 84

XIV Global Interventional Cardiology Devices March ket: Merger and Acquisition Landscape 89
XIV. 1 World Interventional Cardiology Devices March ket: Deals Overview 89
XIV. 2 Key Acquisitions 90
XIV. 2.1 Medtronic Completes Acquisition of Invatec and Affiliated Firms 90
XIV. 2.2 Boston Scientific Takes Over Labcoat 91
XIV. 2.3 St. Jude Medical Takes Over Stake in Micell Technologies 91
XIV. 2.4 Lake Region Medical Takes Over Brivant Medical 91

XV Appendix 92
XV. 1 Definitions 93
XV. 1.1 Interventional Cardiology 93
XV. 1.2 Arteriotomy Closure Devices 93
XV. 1.3 Cardiac Catheter 93
XV. 1.4 Coronary Guidewires 93
XV. 1.5 Coronary Stent 93
XV. 1.6 PTCA Balloon 93
XV. 2 Acronyms 94
XV. 3 Sources 95
XV. 4 Research Methodology 97
XV. 5 Secondary Research 97
XV. 6 Primary Research 97
XV. 7 Models 98
XV. 8 Forecasted data s 98
XV. 9 Expert Panels 98
XV. 10 GlobalData Consulting 98
XV. 11 Contact Us 98
XV. 12 Disclaimer 99

1.1 List of Data tables
Data table 1: Interventional Cardiology Devices March ket, Sales (USD Million), Historical data, 2002–2009 15
Data table 2: Interventional Cardiology Devices March ket, Sales (USD Million), Forecasted data s, 2009–2016 16
Data table 3: Cardiac Catheter March ket, Sales (USD Million), Historical data, 2002–2009 20
Data table 4: Cardiac Catheter March ket, Sales (USD Million), Forecasted data s, 2009–2016 21
Data table 5: Coronary Guidewire March ket, Sales (USD Million), Historical data, 2002–2009 23
Data table 6: Coronary Guidewire March ket, Sales (USD Million), Forecasted data s, 2009–2016 24
Data table 7: Coronary Stent March ket, Sales (USD Million), Historical data, 2002–2009 26
Data table 8: Coronary Stent March ket, Sales (USD Million), Forecasted data s, 2009–2016 27
Data table 9: PTCA Balloon March ket, Sales (USD Million), Historical data, 2002–2009 30
Data table 10: PTCA Balloon March ket, Sales (USD Million), Forecasted data s, 2009–2016 31
Data table 11: Arteriotomy Closure Devices March ket, Sales (USD Million), Historical data, 2002–2009 33
Data table 12: Arteriotomy Closure Devices March ket, Sales (USD Million), Forecasted data s, 2009–2016 34
Data table 13: Interventional Cardiology Devices March ket: March ket Analysis by Country 36
Data table 14: Interventional Cardiology Devices March ket, The US, Sales (USD Million), Historical data, 2002–2009 37
Data table 15: Interventional Cardiology Devices March ket, The US, Sales (USD Million), Forecasted data s, 2009–2016 38
Data table 16: Interventional Cardiology Devices March ket, Canada, Sales (USD Million), Historical data, 2002–2009 39
Data table 17: Interventional Cardiology Devices March ket, Canada, Sales (USD Million), Forecasted data s, 2009–2016 40
Data table 18: Interventional Cardiology Devices March ket, The UK, Sales (USD Million), Historical data, 2002–2009 41
Data table 19: Interventional Cardiology Devices March ket, The UK, Sales (USD Million), Forecasted data s, 2009–2016 42
Data table 20: Interventional Cardiology Devices March ket, France, Sales (USD Million), Historical data, 2002–2009 43
Data table 21: Interventional Cardiology Devices March ket, France, Sales (USD Million), Forecasted data s, 2009–2016 44
Data table 22: Interventional Cardiology Devices March ket, Germany, Sales (USD Million), Historical data, 2002–2009 45
Data table 23: Interventional Cardiology Devices March ket, Germany, Sales (USD Million), Forecasted data s, 2009–2016 46
Data table 24: Interventional Cardiology Devices March ket, Italy, Sales (USD Million), Historical data, 2002–2009 47
Data table 25: Interventional Cardiology Devices March ket, Italy, Sales (USD Million), Forecasted data s, 2009–2016 48
Data table 26: Interventional Cardiology Devices March ket, Spain, Sales (USD Million), Historical data, 2002–2009 49
Data table 27: Interventional Cardiology Devices March ket, Spain, Sales (USD Million), Forecasted data s, 2009–2016 50
Data table 28: Interventional Cardiology Devices March ket, Japan, Sales (USD Million), Historical data, 2002–2009 51
Data table 29: Interventional Cardiology Devices March ket, Japan, Sales (USD Million), Forecasted data s, 2009–2016 52
Data table 30: Interventional Cardiology Devices March ket, China, Sales (USD Million), Historical data, 2002–2009 53
Data table 31: Interventional Cardiology Devices March ket, China, Sales (USD Million), Forecasted data s, 2009–2016 54
Data table 32: Interventional Cardiology Devices March ket, Australia, Sales (USD Million), Historical data, 2002–2009 55
Data table 33: Interventional Cardiology Devices March ket, Australia, Sales (USD Million), Forecasted data s, 2009–2016 56
Data table 34: Interventional Cardiology Devices March ket, India, Sales (USD Million), Historical data, 2002–2009 57
Data table 35: Interventional Cardiology Devices March ket, India, Sales (USD Million), Forecasted data s, 2009–2016 58
Data table 36: Interventional Cardiology Devices March ket, Brazil, Sales (USD Million), Historical data, 2002–2009 59
Data table 37: Interventional Cardiology Devices March ket, Brazil, Sales (USD Million), Forecasted data s, 2009–2016 60
Data table 38: Interventional Cardiology Devices March ket, Key Market Shares s (%), 2009 61
Data table 39: Boston Scientific Corporation, March keted Products, 2010 63
Data table 40: Boston Scientific Group, Pipeline Products, 2010 63
Data table 41: Cordis Corporation, March keted Products, 2010 64
Data table 42: Cordis Corporation, Pipeline Products, 2010 64
Data table 43: Abbott Laboratories, March keted Products, 2010 65
Data table 44: Abbott Laboratories, Pipeline Products, 2010 66
Data table 45: Medtronic, Inc., March keted Products, 2010 67
Data table 46: Medtronic, Inc., Pipeline Products, 2010 67
Data table 47: Terumo Corporation, March keted Products, 2010 68
Data table 48: Terumo Corporation, Pipeline Products, 2010 68
Data table 49: FIRE STAR PTCA Dilatation Catheter, Features, Advantages and Benefits, 2010 69
Data table 50: Apex Monorail PTCA Dilation Catheters, Features, Advantages and Benefits, 2010 69
Data table 51: GTX Guidewires, Features, Advantages and Benefits, 2010 70
Data table 52: BALANCE HI-TORQUE PILOT Coronary Guide Wire, Features, Advantages and Benefits, 2010 70
Data table 53: PROMUS Everolimus-Eluting Coronary Stent System, Features, Advantages and Benefits, 2010 71
Data table 54: CYPHER Sirolimus-eluting Coronary Stent, Features, Advantages and Benefits, 2010 71
Data table 55: Endeavor ABT-578 Eluting Coronary Stent System, Features, Advantages and Benefits, 2010 72
Data table 56: TAXUS Express² Coronary Stent System, Features, Advantages and Benefits, 2010 73
Data table 57: StarClose Vascular Closure Systems, Features, Advantages and Benefits, 2010 73
Data table 58: Interventional Cardiology Devices: Pipeline Products Summary, 2010 74
Data table 59: Angioslide eXtra, Product Status, 2010 75
Data table 60: F.A.S.T. Funnel Catheter, Product Status, 2010 75
Data table 61: CTO Guidewire 0.014, Product Status, 2010 76
Data table 62: Safe-Cross RF CTO System-Next Generation, Product Status, 2010 76
Data table 63: Variable Control Guidewire System, Product Status, 2010 76
Data table 64: Coroflex DEBlue, Product Status, 2010 77
Data table 65: PROTEX Coronary Stent System, Product Status, 2010 77
Data table 66: JST Drug-Eluting Stent, Product Status, 2010 78
Data table 67: XIENCE NANO, Product Status, 2010 78
Data table 68: Zylon Zero-Fold Angioplasty Balloon Catheter, Product Status, 2010 78
Data table 69: Ostial balloon, Product Status, 2010 79
Data table 70: Avion Bifurcation RX2, Product Status, 2010 79
Data table 71: CloSys Hemostasis Device, Product Status, 2010 79
Data table 72: EpiClose Plus, Product Status, 2010 80
Data table 73: Cardiac Catheters, List of Pipeline Products 81
Data table 74: Cardiac Catheter, List of Pipeline Products 82
Data table 75: Arteriotomy Closure Devices, List of Pipeline Products 82
Data table 76: PTCA Balloons, List of Pipeline Products 83
Data table 77: Coronary Stents, List of Pipeline Products 84
Data table 78: World Interventional Cardiology Devices March ket: Number of Deals by Type, 2002–2009 89
Data table 79: World Interventional Cardiology Devices March ket: Deals by Value (USD Million), 2007–2009 90

1.2 List of Charts
Chart 1: Coronary Heart Disease, Signs and Symptoms, 2010 10
Chart 2: Device Based Treatment Modalities for CHD, 2010 11
Chart 3: Interventional Cardiology Devices, March ket Segments, 2010 12
Chart 4: Interventional Cardiology Devices March ket, Sales (USD Million), Historical data, 2002–2009 15
Chart 5: Interventional Cardiology Devices March ket, Sales (USD Million), Forecasted data s, 2009–2016 16
Chart 6: Interventional Cardiology Devices High Number of Me-too Pipeline Products Summary, 2010 17
Chart 7: Cardiac Catheter March ket, Sales (USD Million), Historical data, 2002–2009 20
Chart 8: Cardiac Catheter March ket, Sales (USD Million), Forecasted data s, 2009–2016 21
Chart 9: Coronary Guidewire March ket, Sales (USD Million), Historical data, 2002–2009 23
Chart 10: Coronary Guidewire March ket, Sales (USD Million), Forecasted data s, 2009–2016 24
Chart 11: Coronary Stent March ket, Sales (USD Million), Historical data, 2002–2009 26
Chart 12: Coronary Stent March ket, Sales (USD Million), Forecasted data s, 2009–2016 27
Chart 13: PTCA Balloon March ket, Sales (USD Million), Historical data, 2002–2009 30
Chart 14: PTCA Balloon March ket, Sales (USD Million), Forecasted data s, 2009–2016 31
Chart 15: Arteriotomy Closure Devices March ket, Sales (USD Million), Historical data, 2002–2009 33
Chart 16: Arteriotomy Closure Devices March ket, Sales (USD Million), Forecasted data s, 2009–2016 34
Chart 17: Interventional Cardiology Devices March ket: March ket Analysis by Country 36
Chart 18: Interventional Cardiology Devices March ket, The US, Sales (USD Million), Historical data, 2002–2009 37
Chart 19: Interventional Cardiology Devices March ket, The US, Sales (USD Million), Forecasted data s, 2009–2016 38
Chart 20: Interventional Cardiology Devices March ket, Canada, Sales (USD Million), Historical data, 2002–2009 39
Chart 21: Interventional Cardiology Devices March ket, Canada, Sales (USD Million), Forecasted data s, 2009–2016 40
Chart 22: Interventional Cardiology Devices March ket, The UK, Sales (USD Million), Historical data, 2002–2009 41
Chart 23: Interventional Cardiology Devices March ket, The UK, Sales (USD Million), Forecasted data s, 2009–2016 42
Chart 24: Interventional Cardiology Devices March ket, France, Sales (USD Million), Historical data, 2002–2009 43
Chart 25: Interventional Cardiology Devices March ket, France, Sales (USD Million), Forecasted data s, 2009–2016 44
Chart 26: Interventional Cardiology Devices March ket, Germany, Sales (USD Million), Historical data, 2002–2009 45
Chart 27: Interventional Cardiology Devices March ket, Germany, Sales (USD Million), Forecasted data s, 2009–2016 46
Chart 28: Interventional Cardiology Devices March ket, Italy, Sales (USD Million), Historical data, 2002–2009 47
Chart 29: Interventional Cardiology Devices March ket, Italy, Sales (USD Million), Forecasted data s, 2009–2016 48
Chart 30: Interventional Cardiology Devices March ket, Spain, Sales (USD Million), Historical data, 2002–2009 49
Chart 31: Interventional Cardiology Devices March ket, Spain, Sales (USD Million), Forecasted data s, 2009–2016 50
Chart 32: Interventional Cardiology Devices March ket, Japan, Sales (USD Million), Historical data, 2002–2009 51
Chart 33: Interventional Cardiology Devices March ket, Japan, Sales (USD Million), Forecasted data s, 2009–2016 52
Chart 34: Interventional Cardiology Devices March ket, China, Sales (USD Million), Historical data, 2002–2009 53
Chart 35: Interventional Cardiology Devices March ket, China, Sales (USD Million), Forecasted data s, 2009–2016 54
Chart 36: Interventional Cardiology Devices March ket, Australia, Sales (USD Million), Historical data, 2002–2009 55
Chart 37: Interventional Cardiology Devices March ket, Australia, Sales (USD Million), Forecasted data s, 2009–2016 56
Chart 38: Interventional Cardiology Devices March ket, India, Sales (USD Million), Historical data, 2002–2009 57
Chart 39: Interventional Cardiology Devices March ket, India, Sales (USD Million), Forecasted data s, 2009–2016 58
Chart 40: Interventional Cardiology Devices March ket, Brazil, Sales (USD Million), Historical data, 2002–2009 59
Chart 41: Interventional Cardiology Devices March ket, Brazil, Sales (USD Million), Forecasted data s, 2009–2016 60
Chart 42: Interventional Cardiology Devices March ket, Key Market Shares (%), 2009 61
Chart 43: Interventional Cardiology Devices: Pipeline Products Summary, 2010 74
Chart 44: World Interventional Cardiology Devices March ket: Number of Deals by Type, 2010 89
Chart 45: World Interventional Cardiology Devices March ket: Deals by Value (USD Million), 2007–2009 90

Companies mentioned
Boston Scientific Corporation
Cordis Corporation
Abbott Laboratories
Medtronic, Inc.
Terumo Corporation